Esophageal cancer affects the esophagus lining, causing swallowing difficulty and chest pain. Learn what symptoms to look for ...

Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.

Opdivo (nivolumab) is a prescription drug used ... Opdivo can be prescribed to treat certain kinds of esophageal cancer and gastric (stomach) cancer that have spread to other areas of the body.

Coherus BioSciences, Inc. ( NASDAQ: CHRS) Q4 2024 Earnings Conference Call March 10, 2025 5:00 PM ET Jodi Sievers - Head of IR Denny Lanfear - CEO Paul Reider - CCO Sameer Goregaoker - SVP, ...

Advanced oncology pipeline including more than 20 active Phase 2 and Phase 3 clinical trials with a strategic focus on two priority pan-tumor programs: next-generation immunomodulator candidate BNT327 ...

NEW YORK – Agilent Technologies said on Monday that it has received certification under the EU's In Vitro Diagnostic Regulation for the expanded use of a PD-L1 assay as a companion diagnostic test to ...

The main cancer type in these patients ... hepatocellular carcinoma, gastro-esophageal reflux disease, osteoporosis. Sixteen patients were treated with other drugs, of which 7 (22.6%) received ...

Effect of nivolumab combined with definitive chemoradiotherapy on response rate for esophageal cancer: An immune active intrinsic subtype could be its biomarker—The NOBEL trial.

A multi-site study, backed by an $8 million NIH grant, will evaluate the effectiveness of Lucid Diagnostics' EsoCheck and ...

Our data clearly show that it is feasible and safe to implement stepwise acceleration of nivolumab and pembrolizumab administration to a 10-minute infusion time,” the researchers wrote.